Receptor heteromerization and drug discovery
Top Cited Papers
- 7 January 2010
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 31 (3), 124-130
- https://doi.org/10.1016/j.tips.2009.11.008
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Building a new conceptual framework for receptor heteromersNature Chemical Biology, 2009
- Cell surface targeting of μ-δ opioid receptor heterodimers by RTP4Proceedings of the National Academy of Sciences, 2008
- Dopamine D2 receptors form higher order oligomers at physiological expression levelsThe EMBO Journal, 2008
- How and why do GPCRs dimerize?Trends in Pharmacological Sciences, 2008
- G‐protein‐coupled receptor heteromers: function and ligand pharmacologyBritish Journal of Pharmacology, 2008
- Identification of a serotonin/glutamate receptor complex implicated in psychosisNature, 2008
- Augmentation of spinal morphine analgesia and inhibition of tolerance by low doses of μ- and δ -opioid receptor antagonistsBritish Journal of Pharmacology, 2007
- Receptor heterodimerization leads to a switch in signaling: β‐arrestin2‐mediated ERK activation by μ‐δ opioid receptor heterodimersThe FASEB Journal, 2007
- D1–D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of G q /11 in the striatumProceedings of the National Academy of Sciences, 2007
- Airway smooth muscle prostaglandin-EP1 receptors directly modulate 2-adrenergic receptors within a unique heterodimeric complexJournal of Clinical Investigation, 2006